The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 36 | — | 20.1x | Near average | |
Growth | 23 | -12.8% | 5.6% | Below average | |
Quality | 66 | 375.5% | 7.6% | Near average | |
Safety | 38 | 2.5x | 0.4x | Near average | |
Capital Return | 41 | — | 2.19% | Near average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
Ocular Therapeutix, Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Ocular Therapeutix, Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
OCUL stock shows remarkable stability in analyst estimates over the past 30 days, with the average price target holding steady at 25.5 dollars, representing a significant premium compared to the current price (8.23 dollars). The consistency of the consensus among the three analysts following the stock reflects a state of sustained optimism, despite a Dispersion in the price range between 21 and 30 dollars, indicating agreement on the high intrinsic value with slight differences in estimating growth velocity.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.